Loading…

Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase

The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal 2012-12, Vol.18 (49), p.15772-15781
Main Authors: Sawa, Ryuichi, Takahashi, Yoshiaki, Hashizume, Hideki, Sasaki, Kazushige, Ishizaki, Yoshimasa, Umekita, Maya, Hatano, Masaki, Abe, Hikaru, Watanabe, Takumi, Kinoshita, Naoko, Homma, Yoshiko, Hayashi, Chigusa, Inoue, Kunio, Ohba, Syunichi, Masuda, Toru, Arakawa, Masayuki, Kobayashi, Yoshihiko, Hamada, Masa, Igarashi, Masayuki, Adachi, Hayamitsu, Nishimura, Yoshio, Akamatsu, Yuzuru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43
cites cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43
container_end_page 15781
container_issue 49
container_start_page 15772
container_title Chemistry : a European journal
container_volume 18
creator Sawa, Ryuichi
Takahashi, Yoshiaki
Hashizume, Hideki
Sasaki, Kazushige
Ishizaki, Yoshimasa
Umekita, Maya
Hatano, Masaki
Abe, Hikaru
Watanabe, Takumi
Kinoshita, Naoko
Homma, Yoshiko
Hayashi, Chigusa
Inoue, Kunio
Ohba, Syunichi
Masuda, Toru
Arakawa, Masayuki
Kobayashi, Yoshihiko
Hamada, Masa
Igarashi, Masayuki
Adachi, Hayamitsu
Nishimura, Yoshio
Akamatsu, Yuzuru
description The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors. Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).
doi_str_mv 10.1002/chem.201202645
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1778043062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1439227389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</originalsourceid><addsrcrecordid>eNqF0c1v0zAYBnALgVgZXDmiSFy4pPP3B7eu27qJUSQo4mg5tsM8krizE1j_-6XqqKZderIPv-eRXj0AvEdwiiDEJ_bGt1MMEYaYU_YCTBDDqCSCs5dgAhUVJWdEHYE3Od9CCBUn5DU4wgRhRSmZgO-zdmNjY9pgQ_e5mBXL-Nc3xWmKxpU_1t72aWiLWdeHKsQ-2OKquxm_feh-F6fG9j4F0xSruI4hx9Ynk_1b8Ko2TfbvHt9j8PPifDW_LK-_La7ms-vSMkpYqaSpJIJWOMw5prUUznnv6trVzmNPlWCVkbVyFXKmMkhYScx4M6-RtNRScgw-7XrXKd4NPve6Ddn6pjGdj0PWSAgJKYEcH6aUKIwFkeowRUpQyRDZ0o_P6G0cUjfePCrJMeQKiVFNd8qmmHPytV6n0Jq00Qjq7YZ6u6HebzgGPjzWDlXr3Z7_H20Eagf-hcZvDtTp-eX516fl5S4bcu_v91mT_mguiGD613Kh5ZezBV6erTQlD_ZXtno</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1186206917</pqid></control><display><type>article</type><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><source>Wiley</source><creator>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</creator><creatorcontrib>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</creatorcontrib><description>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors. Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</description><identifier>ISSN: 0947-6539</identifier><identifier>EISSN: 1521-3765</identifier><identifier>DOI: 10.1002/chem.201202645</identifier><identifier>PMID: 23129443</identifier><identifier>CODEN: CEUJED</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibiotics ; Bacteria ; Bacteria - drug effects ; Binding ; Biophysics ; Chemistry ; Deoxyribonucleic acid ; DNA ; DNA replication ; DNA Topoisomerase IV - antagonists &amp; inhibitors ; DNA Topoisomerase IV - chemistry ; Glucosides - chemistry ; Glucosides - pharmacology ; Inhibitors ; Magnetic Resonance Spectroscopy ; Methyl alcohol ; Microbial Sensitivity Tests ; natural products ; Pathogens ; Pyrroles - chemistry ; Pyrroles - pharmacology ; Spectrum analysis ; Staphylococcus aureus ; structure elucidation ; Topoisomerase II Inhibitors</subject><ispartof>Chemistry : a European journal, 2012-12, Vol.18 (49), p.15772-15781</ispartof><rights>Copyright © 2012 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</citedby><cites>FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23129443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sawa, Ryuichi</creatorcontrib><creatorcontrib>Takahashi, Yoshiaki</creatorcontrib><creatorcontrib>Hashizume, Hideki</creatorcontrib><creatorcontrib>Sasaki, Kazushige</creatorcontrib><creatorcontrib>Ishizaki, Yoshimasa</creatorcontrib><creatorcontrib>Umekita, Maya</creatorcontrib><creatorcontrib>Hatano, Masaki</creatorcontrib><creatorcontrib>Abe, Hikaru</creatorcontrib><creatorcontrib>Watanabe, Takumi</creatorcontrib><creatorcontrib>Kinoshita, Naoko</creatorcontrib><creatorcontrib>Homma, Yoshiko</creatorcontrib><creatorcontrib>Hayashi, Chigusa</creatorcontrib><creatorcontrib>Inoue, Kunio</creatorcontrib><creatorcontrib>Ohba, Syunichi</creatorcontrib><creatorcontrib>Masuda, Toru</creatorcontrib><creatorcontrib>Arakawa, Masayuki</creatorcontrib><creatorcontrib>Kobayashi, Yoshihiko</creatorcontrib><creatorcontrib>Hamada, Masa</creatorcontrib><creatorcontrib>Igarashi, Masayuki</creatorcontrib><creatorcontrib>Adachi, Hayamitsu</creatorcontrib><creatorcontrib>Nishimura, Yoshio</creatorcontrib><creatorcontrib>Akamatsu, Yuzuru</creatorcontrib><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><title>Chemistry : a European journal</title><addtitle>Chem. Eur. J</addtitle><description>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors. Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</description><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Bacteria - drug effects</subject><subject>Binding</subject><subject>Biophysics</subject><subject>Chemistry</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA replication</subject><subject>DNA Topoisomerase IV - antagonists &amp; inhibitors</subject><subject>DNA Topoisomerase IV - chemistry</subject><subject>Glucosides - chemistry</subject><subject>Glucosides - pharmacology</subject><subject>Inhibitors</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Methyl alcohol</subject><subject>Microbial Sensitivity Tests</subject><subject>natural products</subject><subject>Pathogens</subject><subject>Pyrroles - chemistry</subject><subject>Pyrroles - pharmacology</subject><subject>Spectrum analysis</subject><subject>Staphylococcus aureus</subject><subject>structure elucidation</subject><subject>Topoisomerase II Inhibitors</subject><issn>0947-6539</issn><issn>1521-3765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqF0c1v0zAYBnALgVgZXDmiSFy4pPP3B7eu27qJUSQo4mg5tsM8krizE1j_-6XqqKZderIPv-eRXj0AvEdwiiDEJ_bGt1MMEYaYU_YCTBDDqCSCs5dgAhUVJWdEHYE3Od9CCBUn5DU4wgRhRSmZgO-zdmNjY9pgQ_e5mBXL-Nc3xWmKxpU_1t72aWiLWdeHKsQ-2OKquxm_feh-F6fG9j4F0xSruI4hx9Ynk_1b8Ko2TfbvHt9j8PPifDW_LK-_La7ms-vSMkpYqaSpJIJWOMw5prUUznnv6trVzmNPlWCVkbVyFXKmMkhYScx4M6-RtNRScgw-7XrXKd4NPve6Ddn6pjGdj0PWSAgJKYEcH6aUKIwFkeowRUpQyRDZ0o_P6G0cUjfePCrJMeQKiVFNd8qmmHPytV6n0Jq00Qjq7YZ6u6HebzgGPjzWDlXr3Z7_H20Eagf-hcZvDtTp-eX516fl5S4bcu_v91mT_mguiGD613Kh5ZezBV6erTQlD_ZXtno</recordid><startdate>20121203</startdate><enddate>20121203</enddate><creator>Sawa, Ryuichi</creator><creator>Takahashi, Yoshiaki</creator><creator>Hashizume, Hideki</creator><creator>Sasaki, Kazushige</creator><creator>Ishizaki, Yoshimasa</creator><creator>Umekita, Maya</creator><creator>Hatano, Masaki</creator><creator>Abe, Hikaru</creator><creator>Watanabe, Takumi</creator><creator>Kinoshita, Naoko</creator><creator>Homma, Yoshiko</creator><creator>Hayashi, Chigusa</creator><creator>Inoue, Kunio</creator><creator>Ohba, Syunichi</creator><creator>Masuda, Toru</creator><creator>Arakawa, Masayuki</creator><creator>Kobayashi, Yoshihiko</creator><creator>Hamada, Masa</creator><creator>Igarashi, Masayuki</creator><creator>Adachi, Hayamitsu</creator><creator>Nishimura, Yoshio</creator><creator>Akamatsu, Yuzuru</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>K9.</scope><scope>7X8</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TM</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20121203</creationdate><title>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</title><author>Sawa, Ryuichi ; Takahashi, Yoshiaki ; Hashizume, Hideki ; Sasaki, Kazushige ; Ishizaki, Yoshimasa ; Umekita, Maya ; Hatano, Masaki ; Abe, Hikaru ; Watanabe, Takumi ; Kinoshita, Naoko ; Homma, Yoshiko ; Hayashi, Chigusa ; Inoue, Kunio ; Ohba, Syunichi ; Masuda, Toru ; Arakawa, Masayuki ; Kobayashi, Yoshihiko ; Hamada, Masa ; Igarashi, Masayuki ; Adachi, Hayamitsu ; Nishimura, Yoshio ; Akamatsu, Yuzuru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Bacteria - drug effects</topic><topic>Binding</topic><topic>Biophysics</topic><topic>Chemistry</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA replication</topic><topic>DNA Topoisomerase IV - antagonists &amp; inhibitors</topic><topic>DNA Topoisomerase IV - chemistry</topic><topic>Glucosides - chemistry</topic><topic>Glucosides - pharmacology</topic><topic>Inhibitors</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Methyl alcohol</topic><topic>Microbial Sensitivity Tests</topic><topic>natural products</topic><topic>Pathogens</topic><topic>Pyrroles - chemistry</topic><topic>Pyrroles - pharmacology</topic><topic>Spectrum analysis</topic><topic>Staphylococcus aureus</topic><topic>structure elucidation</topic><topic>Topoisomerase II Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sawa, Ryuichi</creatorcontrib><creatorcontrib>Takahashi, Yoshiaki</creatorcontrib><creatorcontrib>Hashizume, Hideki</creatorcontrib><creatorcontrib>Sasaki, Kazushige</creatorcontrib><creatorcontrib>Ishizaki, Yoshimasa</creatorcontrib><creatorcontrib>Umekita, Maya</creatorcontrib><creatorcontrib>Hatano, Masaki</creatorcontrib><creatorcontrib>Abe, Hikaru</creatorcontrib><creatorcontrib>Watanabe, Takumi</creatorcontrib><creatorcontrib>Kinoshita, Naoko</creatorcontrib><creatorcontrib>Homma, Yoshiko</creatorcontrib><creatorcontrib>Hayashi, Chigusa</creatorcontrib><creatorcontrib>Inoue, Kunio</creatorcontrib><creatorcontrib>Ohba, Syunichi</creatorcontrib><creatorcontrib>Masuda, Toru</creatorcontrib><creatorcontrib>Arakawa, Masayuki</creatorcontrib><creatorcontrib>Kobayashi, Yoshihiko</creatorcontrib><creatorcontrib>Hamada, Masa</creatorcontrib><creatorcontrib>Igarashi, Masayuki</creatorcontrib><creatorcontrib>Adachi, Hayamitsu</creatorcontrib><creatorcontrib>Nishimura, Yoshio</creatorcontrib><creatorcontrib>Akamatsu, Yuzuru</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Chemistry : a European journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sawa, Ryuichi</au><au>Takahashi, Yoshiaki</au><au>Hashizume, Hideki</au><au>Sasaki, Kazushige</au><au>Ishizaki, Yoshimasa</au><au>Umekita, Maya</au><au>Hatano, Masaki</au><au>Abe, Hikaru</au><au>Watanabe, Takumi</au><au>Kinoshita, Naoko</au><au>Homma, Yoshiko</au><au>Hayashi, Chigusa</au><au>Inoue, Kunio</au><au>Ohba, Syunichi</au><au>Masuda, Toru</au><au>Arakawa, Masayuki</au><au>Kobayashi, Yoshihiko</au><au>Hamada, Masa</au><au>Igarashi, Masayuki</au><au>Adachi, Hayamitsu</au><au>Nishimura, Yoshio</au><au>Akamatsu, Yuzuru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase</atitle><jtitle>Chemistry : a European journal</jtitle><addtitle>Chem. Eur. J</addtitle><date>2012-12-03</date><risdate>2012</risdate><volume>18</volume><issue>49</issue><spage>15772</spage><epage>15781</epage><pages>15772-15781</pages><issn>0947-6539</issn><eissn>1521-3765</eissn><coden>CEUJED</coden><abstract>The abuse of antibacterial drugs imposes a selection pressure on bacteria that has driven the evolution of multidrug resistance in many pathogens. Our efforts to discover novel classes of antibiotics to combat these pathogens resulted in the discovery of amycolamicin (AMM). The absolute structure of AMM was determined by NMR spectroscopy, X‐ray analysis, chemical degradation, and modification of its functional groups. AMM consists of trans‐decalin, tetramic acid, two unusual sugars (amycolose and amykitanose), and dichloropyrrole carboxylic acid. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is a potent and broad‐spectrum antibiotic against Gram‐positive pathogenic bacteria by inhibiting DNA gyrase and bacterial topoisomerase IV. The target of AMM has been proved to be the DNA gyrase B subunit and its binding mode to DNA gyrase is different from those of novobiocin and coumermycin, the known DNA gyrase inhibitors. Equilibrium structure: Amycolamicin (AMM) was discovered as a new antibiotic and its absolute structure was determined. The pyranose ring named as amykitanose undergoes anomerization in methanol. AMM is effective against methicillin‐resistant Staphylococcus aureus and its strains, which are resistant to known DNA gyrase inhibitors. AMM is a potent and selective inhibitor of DNA gyrase and it does not inhibit human topoisomerase II (see figure).</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>23129443</pmid><doi>10.1002/chem.201202645</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0947-6539
ispartof Chemistry : a European journal, 2012-12, Vol.18 (49), p.15772-15781
issn 0947-6539
1521-3765
language eng
recordid cdi_proquest_miscellaneous_1778043062
source Wiley
subjects Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antibiotics
Bacteria
Bacteria - drug effects
Binding
Biophysics
Chemistry
Deoxyribonucleic acid
DNA
DNA replication
DNA Topoisomerase IV - antagonists & inhibitors
DNA Topoisomerase IV - chemistry
Glucosides - chemistry
Glucosides - pharmacology
Inhibitors
Magnetic Resonance Spectroscopy
Methyl alcohol
Microbial Sensitivity Tests
natural products
Pathogens
Pyrroles - chemistry
Pyrroles - pharmacology
Spectrum analysis
Staphylococcus aureus
structure elucidation
Topoisomerase II Inhibitors
title Amycolamicin: A Novel Broad-Spectrum Antibiotic Inhibiting Bacterial Topoisomerase
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T00%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amycolamicin:%20A%20Novel%20Broad-Spectrum%20Antibiotic%20Inhibiting%20Bacterial%20Topoisomerase&rft.jtitle=Chemistry%20:%20a%20European%20journal&rft.au=Sawa,%20Ryuichi&rft.date=2012-12-03&rft.volume=18&rft.issue=49&rft.spage=15772&rft.epage=15781&rft.pages=15772-15781&rft.issn=0947-6539&rft.eissn=1521-3765&rft.coden=CEUJED&rft_id=info:doi/10.1002/chem.201202645&rft_dat=%3Cproquest_cross%3E1439227389%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5435-98ab810c7d26624f87ddeedffdfde2e4975ba8f9db1daba17c83a1006f18c4c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1186206917&rft_id=info:pmid/23129443&rfr_iscdi=true